Showing 8151-8160 of 20420 results for "".
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
https://reachmd.com/programs/neurofrontiers/consensus-driven-outcomes-aneurysmal-subarachnoid-hemorrhage-research/57156/Colorectal Cancer in Young Patients: A Multidisciplinary Approach
https://reachmd.com/programs/gi-insights/colorectal-cancer-in-young-patients-a-multidisciplinary-approach/15981/Colorectal cancer rates are rising among young patients. Here’s why a multidisciplinary treatment approach is key.Combatting Challenges & Health Disparities in Colorectal Cancer Care
https://reachmd.com/programs/project-oncology/combatting-challenges-health-disparities-in-colorectal-cancer-care/13533/What are some obstacles preventing access to colorectal cancer screening—and how can we overcome them?Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
https://reachmd.com/programs/clinicians-roundtable/teledermatology-enables-earlier-diagnosis-of-cutaneous-squamous-cell-carcinoma/54695/Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
https://reachmd.com/programs/clinicians-roundtable/smoking-status-predicts-worse-survival-in-non-melanoma-skin-cancer/54697/Telemedicine and School-Based Asthma Care: Evidence from TEAM-UP
https://reachmd.com/programs/clinicians-roundtable/telemedicine-and-school-based-asthma-care-evidence-from-team-up/54185/Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
https://reachmd.com/programs/project-oncology/expanding-access-to-car-t-cell-therapy-in-rr-myeloma-care/48731/This is a non-certified educational series produced and controlled by ReachMD. While BCMA-directed CAR T-cell therapy has changed the treatment landscape for patients with relapsed and refractory (R/R) multiple myeloma, access remains uneven outside academic centers. In this expert-led discussion, DAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
https://reachmd.com/programs/neurofrontiers/advancing-schizophrenia-care-when-and-how-to-use-novel-therapies-in-complex-patients/36642/Treating schizophrenia is rarely a one-size-fits-all approach, especially for patients who’ve cycled through multiple antipsychotics with limited success. In these complex cases, knowing when and how to consider novel mechanisms of action beyond traditional D2-blocking agents is essential. Joining DNext-Generation Horizons in PNH Therapies
https://reachmd.com/programs/project-oncology/next-generation-horizons-in-pnh-therapies/48873/What can we expect from PNH therapies that are on the horizon? Tune in to learn more.Stories in PNH: Case Experiences from the Clinic
https://reachmd.com/programs/project-oncology/stories-in-pnh-case-experiences-from-the-clinic/48872/What are some effective PNH patient management strat